Stay updated on Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record for a Phase Ib/II trial of fruquintinib alone or with sintilimab is now displayed instead of an access-denied page. It includes detailed study design, participation criteria, outcome measures, record dates, and related publications.
    Difference
    55%
    Check dated 2026-11-08T15:29:33.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:30:52.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The record now displays details for a completed Phase Ib/II study of fruquintinib alone or with sintilimab, including eligibility criteria, treatment arms, outcomes, and study history.
    Difference
    57%
    Check dated 2026-10-25T16:34:35.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T20:51:31.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision number changes from v3.7.0 to v3.7.1 while the study page remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-11T20:42:51.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the usual study details and navigation. This blocks access to trial information that users expect to find on the page.
    Difference
    20%
    Check dated 2026-09-20T22:34:15.000Z thumbnail image

Stay in the know with updates to Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.